News
Web & Podcasts
What’s On
Show submenu for What’s On
Webinars
Events
About Us
Show submenu for About Us
Who We Are
Our Contributors
Advertise
Contact
News
Web & Podcasts
What’s On
Show submenu for What’s On
Webinars
Events
About Us
Show submenu for About Us
Who We Are
Our Contributors
Advertise
Contact
PARKD Secures Five-Year Licensing Deal with Fielders, Setting Stage for Market Expansion
Wrkr Limited Sets the Stage for Growth Despite Flat Quarter
Fluence Bounces Back in Q4, Eyes Strong Growth in 2025
Wellnex Life handed new MA for its liquid soft gels range
Noxopharm's SOF-SKN passes required in vitro safety tests
India’s Scrap Duty Cuts: A Game-Changer for MTM Critical Metals’ Recycling Breakthrough
Audeara Hits the Right Note with Zildjian: A $917,000 Deal That Harmonises Innovation and Tradition
Paradigm selects Advanced Clinical as CRO for Phase 3
Neurotech receives $2.44M R&D Tax Incentive refund
PainChek Expands in US as AI Pain Detection Gains Global Traction
Q&A With Dr David Ali From Memphasys Reproductive Biotechnology (ASX:MEM)
Staff Writers
12 June, 2023
Pharmaceuticals
SHARE
SHARE
Rate video from Staff Writers:
Related Videos & Media on TechInvest
29 September, 2023
Memphasys (ASX:MEM) Investor Webinar - 21 Sept 2023
Watch video
Innovation
3 April, 2023
Memphasys Limited ASX Announcement
Watch video